Advertisement

Mycoplasma pneumoniae and Other Human Mycoplasmas

  • Deborah F. Talkington
  • Ken B. Waites
Chapter

Mycoplasmas are a class of fascinating wall-less bacteria that cause disease in humans, animals, and plants. They include species recognized as among the smallest known free-living cells. These microbes have very small genomes and unique genetic features. Their temporary classification as viruses and fastidious growth requirements set the stage early for the use of diagnostic techniques better suited to viral detection and for the well-known difficulties of diagnosing infections in the clinical laboratory. Systemic infections are well known in both immunocompetent and immunocompromised patients, but the host and bacterial factors that allow invasion from epithelial colonization sites are poorly understood. The focus of this chapter will be respiratory and extrapulmonary infections caused by Mycoplasma pneumoniae and genitourinary tract infections caused by M. hominis, M. genitalium, and Ureaplasma species. Some less common mycoplasma infections will also be addressed.

Keywords

Polymerase Chain Reaction Assay Thrombotic Thrombocytopenic Purpura Urogenital Tract Mycoplasmal Pneumonia Mycoplasma Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Nocard, E. and E.R. Roux, Le microbe de la peripneumonie. Ann. Inst. Pasteur (Paris), 1898. 12: 240–262.Google Scholar
  2. 2.
    Klieneberger, E., The natural occurrence of pleuropneumonia-like organisms in apparent symbiosis with Streptobacillus moniliformis and other bacteria. J. Pathol. Bacteriol., 1935. 40: 93–105.CrossRefGoogle Scholar
  3. 3.
    Dienes, L. and G. Edsall, Observations on the L-organisms of Klieneberger. Proc. Soc. Exp. Biol. Med., 1937. 36: 740–744.Google Scholar
  4. 4.
    Talkington, D.F., et al., Emerging from obscurity: understanding pulmonary and extrapulmonary syndromes, pathogenesis, and epidemiology of human Mycoplasma pneumoniae infections, in Emerging Infections, W.M. Scheld, W.A. Craig, and A.J.M. Hughes, Editors. 2001, American Society for Microbiology: Washington, DC. pp. 57–84.Google Scholar
  5. 5.
    Waites, K.B. and D.F. Talkington, Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev., 2004. 17(4): 697–728, table of contents.PubMedCrossRefGoogle Scholar
  6. 6.
    Talkington, D.F., Mycoplasma and Ureaplasma in central nervous system disorders., in Infections of the central nervous system, M. Scheld, R. Whitley, and a.C. Marra, Editors. 2005, Lippincott, Williams & Wilkins: Philadelphia, PA. pp. 605–611.Google Scholar
  7. 7.
    Eaton, M.D., G. Meikeljohn, and W. Van Herick, Studies on the etiology of primary atypical pneumonia: A filterable agent transmissible to cotton rats, hamsters, and chick embryos. J. Exp. Med., 1944. 79: 649–668.PubMedCrossRefGoogle Scholar
  8. 8.
    Chanock, R.M., et al., Serologic evidence of infection with Eaton agent in lower respiratory illness of childhood. N. Engl. J. Med., 1960. 262: 648–654.Google Scholar
  9. 9.
    Chanock, R.M., et al., Respiratory disease in volunteers infected with Eaton agent: A preliminary report. Proc. Natl. Acad. Sci. USA, 1961. 47: 887–890.Google Scholar
  10. 10.
    Marmion, B.P. and a.G.M. Goodburn, Effect of an inorganic gold salt on Eaton's primary atypical pneumonia agent and other observations. Nature, 1961. 189: 247–248.PubMedCrossRefGoogle Scholar
  11. 11.
    Chanock, R.M., et al., Mycoplasma pneumoniae: proposed nomenclature for atypical pneumonia organism (Eaton agent). Science, 1963. 140: 662.PubMedCrossRefGoogle Scholar
  12. 12.
    Feikin, D.R., et al., An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy: new implications from an old scenario. Clin. Infect. Dis., 1999. 29(6): 1545–1550.PubMedCrossRefGoogle Scholar
  13. 13.
    Meseguer, M.A., et al., Mycoplasma pneumoniae pericarditis and cardiac tamponade in a ten-year-old girl. Pediatr. Infect. Dis. J., 1996. 15: 829–831.PubMedCrossRefGoogle Scholar
  14. 14.
    Foy, H.M., et al., Epidemiology of Mycoplasma pneumoniae infection in families. JAMA, 1966. 197(11): 859–66.PubMedCrossRefGoogle Scholar
  15. 15.
    Marston, B.J., et al., Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch. Intern. Med., 1997. 157: 1709–1718.PubMedCrossRefGoogle Scholar
  16. 16.
    Benisch, B.M., A. Fayemi, M.A. Gerber, and J. Axelrod, Mycoplasmal pneumonia in a patient with rheumatic heart disease. Am. J. Clin. Pathol., 1972. 58: 343–348.PubMedGoogle Scholar
  17. 17.
    Rawadi, G., and S. Roman-Roman, Mycoplasma membrane lipoproteins induce proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect. Immun., 1996. 64: 637–643.PubMedGoogle Scholar
  18. 18.
    Seggev, J.S., G.V. Sedmak, and V.P. Kurup, Isotype specific antibody responses to acute Mycoplasma pneumoniae infection. Ann. Allergy Asthma Immunol., 1996. 77: 67–73.PubMedCrossRefGoogle Scholar
  19. 19.
    Kenney, R.T., et al., Mycoplasma pericarditis: Evidence of invasive disease. Clin. Infect. Dis., 1993. 17(Suppl. 1): S58–S62.PubMedCrossRefGoogle Scholar
  20. 20.
    Whyte, K.F., and G.R. Williams, Bronchiectasis after mycoplasma pneumonia. Thorax, 1984. 39: 390–391.PubMedCrossRefGoogle Scholar
  21. 21.
    Said, M.H., et al., Mycoplasma pneumoniae-associated nephritis in children. Pediatr. Nephrol., 1999. 13: 39–44.PubMedCrossRefGoogle Scholar
  22. 22.
    Brouard, J., et al., Mycoplasma pneumoniae respiratory infection in a child presenting with positive HIV 1 serology. Arch. Fr. Pediatr., 1989. 46: 155–156.PubMedGoogle Scholar
  23. 23.
    Feizi, T., et al., Studies on an epidemic of respiratory disease caused by Mycoplasma pneumoniae. Br. Med. J., 1967. 1:457–460.PubMedCrossRefGoogle Scholar
  24. 24.
    Root-Bernstein, R.S. and S.H. Hobbs, Homologies between mycoplasma adhesion peptide, CD4 and class II MHC proteins: a possible mechanism for HIV-mycoplasma synergism in AIDS. Res. Immunol., 1991. 142: 519–523.PubMedCrossRefGoogle Scholar
  25. 25.
    Ponka, A., The occurrence and clinical picture of serologically verified Mycoplasma pneumoniae infections with emphasis on central nervous system, cardiac and joint manifestations. Ann. Clin. Res., 1979. 11(Suppl. 24): 1–60.PubMedGoogle Scholar
  26. 26.
    Taylor-Robinson, D., et al., Isolation of Mycoplasma pneumoniae from the synovial fluid of a hypogammaglobulinaemic patient in a survey of patients with inflammatory polyarthritis. Ann. Rheum. Dis., 1978. 37: 180–182.PubMedCrossRefGoogle Scholar
  27. 27.
    Weinstein, M.P. and C.B. Hall, Mycoplasma pneumoniae infection associated with migratory polyarthritis. Am. J. Dis. Child., 1974. 127: 125–126.PubMedGoogle Scholar
  28. 28.
    Baseman, J.B. and J.G. Tully, Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg. Infect. Dis., 1997. 3: 21–32.PubMedCrossRefGoogle Scholar
  29. 29.
    Chang, Y.T., Yang, Y.H., Chiang, B.L., The significance of a rapid cold hemagglutination test for detecting mycoplasma infections in children with asthma exacerbation. J. Microbiol. Immunol. Infect., 2006. 39(1): 28–32.PubMedGoogle Scholar
  30. 30.
    Tully, J.G., et al., Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly modified culture medium. J. Infect. Dis., 1979. 139: 478–482.PubMedCrossRefGoogle Scholar
  31. 31.
    Waites, K.B., D.F. Talkington, and a.C.M. Bebear, Mycoplasmas, in Manual of commercial methods in clinical microbiology., A.L. Truant, Editor. 2002, American Society for Microbiology: Washington, D.C. pp. 201–224.Google Scholar
  32. 32.
    Waites, K.B., et al., Laboratory diagnosis of mycoplasmal infections, in Cumitech 34 2001, Washington, D.C.Google Scholar
  33. 33.
    Ieven, M., et al., Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J. Infect. Dis., 1996. 173: 1445–1452.PubMedCrossRefGoogle Scholar
  34. 34.
    Dorigo-Zetsma, J.W., et al., Demonstration by a nested PCR for Mycoplasma pneumoniae that M. pneumoniae load in the throat is higher in patients hospitalised for M. pneumoniae infection than in non-hospitalised subjects. J. Med. Microbiol., 1999. 48:1115–1122.PubMedCrossRefGoogle Scholar
  35. 35.
    Thacker, W.L. and D.F. Talkington, Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin. Diagn. Lab Immunol., 2000. 7(5): 778–80.PubMedGoogle Scholar
  36. 36.
    Talkington, D.F., et al., Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin. Diagn. Lab Immunol., 2004. 11(5): 862–867.PubMedGoogle Scholar
  37. 37.
    Thacker, W.L. and D.F. Talkington, Comparison of two rapid commercial tests with complement fixation for serologic diagnosis of Mycoplasma pneumoniae infections. J. Clin. Microbiol., 1995. 33(5): 1212–1214.PubMedGoogle Scholar
  38. 38.
    Alexander, T.S., et al., Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial. J. Clin. Microbiol, 1996. 34: 1180–1183.PubMedGoogle Scholar
  39. 39.
    Matas, L., et al., Evaluation of Meridian ImmunoCard Mycoplasma test for the detection of Mycoplasma pneumoniae specific IgM in paediatric patients. Scand. J. Infect. Dis., 1998. 30:289–293.PubMedCrossRefGoogle Scholar
  40. 40.
    Waris, M.E., P. Toikka, T. Saarinen, S. Nikkari, O. Meurman, R. Vainionpaa, O. Ruuskanen and J. Mertsola, Diagnosis of Mycoplasma pneumoniae in children. J. Clin. Microbiol., 1998. 36: 3155–3159.PubMedGoogle Scholar
  41. 41.
    Chamberlin, P., and A.A. Saeed, A study of the specific IgM antibody response in Mycoplasma pneumoniae in man. J. Hyg. (Cambridge), 1983. 90: 207–211.CrossRefGoogle Scholar
  42. 42.
    Biberfield, G., Antibody responses in Mycoplasma pneumoniae infection in relation to serum immunoglobulins, especially IgM. Acta Pathol. Microbiol. Scand., 1971. Sect. B 79: 620–634.Google Scholar
  43. 43.
    Vikerfors, T., G. Brodin, M. Grandien, L. Hirschberg, A. Krook, and C.A. and Petterson, Detection of specific IgM antibodies for the diagnosis of Mycoplasma pneumoniae infections: a clinical evaluation. Scand. J. Infect. Dis., 1988. 20: 601–610.PubMedCrossRefGoogle Scholar
  44. 44.
    Gerstenecker, B. and E. Jacobs, Development of a capture-ELISA for the specific detection of Mycoplasma pneumoniae in patient’s material., in Rapid diagnosis of mycoplasmas., I. Kahane and a.A. Adoni, Editors. 1993, Plenum Press: New York, N.Y. pp. 195–205.Google Scholar
  45. 45.
    Kok, T.W., et al., Laboratory diagnosis of Mycoplasma pneumoniae infection. 1. Direct detection of antigen in respiratory exudates by enzyme immunoassay. Epidemiol. Infect., 1988. 101: 669–684.PubMedCrossRefGoogle Scholar
  46. 46.
    Hirschberg, L. and T. Holme, ELISA for detection of Mycoplasma pneumoniae antigens using monoclonal antibodies. APMIS, 1991. 99: 475–481.PubMedCrossRefGoogle Scholar
  47. 47.
    Bernet, C., et al., Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J. Clin. Microbiol., 1989. 27: 2492–2496.PubMedGoogle Scholar
  48. 48.
    Daxboeck, F., R. Krause, and a.C. Wenisch, Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin. Microbiol. Infect., 2003. 9: 263–273.Google Scholar
  49. 49.
    Loens, K., et al., Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J. Clin. Microbiol., 2003. 41:4915–4923.PubMedCrossRefGoogle Scholar
  50. 50.
    Murdoch, D.R., Nucleic acid amplification tests for the diagnosis of pneumonia. Clin. Infect. Dis., 2003. 36: 1162–1170.PubMedCrossRefGoogle Scholar
  51. 51.
    Waites, K.B., et al., In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob. Agents Chemother., 2003. 47(1): 161–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Waites, K.B., D.M. Crabb, and L.B. Duffy, In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas. Antimicrob. Agents Chemother., 2003. 47: 39–42.PubMedCrossRefGoogle Scholar
  53. 53.
    Clyde, W.A., Jr., Mycoplasma pneumoniae infections of man, in The mycoplasmas. II. Human and animal mycoplasmas., J.G. Tully and a.R.F. Whitcomb, Editors. 1979, Academic Press: New York, N.Y. pp. 275–306.Google Scholar
  54. 54.
    Kenny, G.E. and a.F.D. Cartwright, Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin- dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob. Agents Chemother., 2001. 45:2604–2608.PubMedCrossRefGoogle Scholar
  55. 55.
    Waites, K.B., D.M. Crabb, and L.B. Duffy, Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae. Int. J. Antimicrob. Agents, 2003. 21: 574–577.PubMedCrossRefGoogle Scholar
  56. 56.
    Bebear, C.M., et al., Comparative activities of telithromycin (HMR 3647), levofloxacin and other antimicrobial agents against human mycoplasmas. Antimicrob. Agents Chemother., 2000. 47: 1980–1982.CrossRefGoogle Scholar
  57. 57.
    Duffy, L.B., et al., Bactericidal activity of levofloxacin against Mycoplasma pneumoniae. J Antimicrob Chemother, 2003. 52(3): 527–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Bebear, C., et al., Potential improvements in therapeutic options for mycoplasmal respiratory infections. Clin. Infect. Dis., 1993. 17(Suppl. 1): S202–S207.PubMedCrossRefGoogle Scholar
  59. 59.
    Bebear, C.M. and C. Bebear, Antimycoplasmal agents., in Molecular biology and pathogenicity of mycoplasmas., S. Razin and a.R. Herrmann, Editors. 2002, Kluwer Academic/Plenum Publishers: New York, N.Y. pp. 545–566.CrossRefGoogle Scholar
  60. 60.
    Niitu, Y., et al., Susceptibility of Mycoplasma pneumoniae to antibiotics in vitro. Jpn. J. Microbiol., 1974. 18: 149–155.PubMedGoogle Scholar
  61. 61.
    Niitu, Y., et al., Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. J. Pediatr., 1970. 76: 438–443.PubMedCrossRefGoogle Scholar
  62. 62.
    Stopler, T., C.B. Gerichter, and a.D. Branski, Antibiotic-resistant mutants of Mycoplasma pneumoniae. Isr. J. Med. Sci., 1980. 16: 169–173.PubMedGoogle Scholar
  63. 63.
    Marrie, T.J., Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch. Intern. Med., 1993. 153: 488–494.PubMedCrossRefGoogle Scholar
  64. 64.
    Rossi, O.V., V.L. Kinnula, H. Tuokko, and E. Huhti, Respiratory viral and Mycoplasma infections in patients hospitalized for acute asthma. Monaldi Arch. Chest Dis., 1994. 49: 107–111.PubMedGoogle Scholar
  65. 65.
    Daian, C.M., A.H. Wolff, and L. Bielory, The role of atypical organisms in asthma. Allergy Asthma Proc., 2000. 21: 107–111.PubMedCrossRefGoogle Scholar
  66. 66.
    Micillo, E., A. Bianco, D. D’Auria, G. Mazzarella, and G.F. Abbate, Respiratory infections and asthma. Allergy Asthma Proc., 2000. 55 (Suppl 61): 42–45.Google Scholar
  67. 67.
    Seggev, J.S., et al., Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann. Allergy, 1986. 57: 263–265.PubMedGoogle Scholar
  68. 68.
    Terttu HH, L.M., Nokso-Koivisto J, Korhonen T, Raty R, He Q, Hovi T, Mertsola J, Bloigu A, Rytila P, Saikku P, Non-random distribution of pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma. Thorax, 2006. March 3: Electronic preprint.Google Scholar
  69. 69.
    Gil, J.C., et al., Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann. Allergy, 1993. 70: 23–25.PubMedGoogle Scholar
  70. 70.
    Kraft, M., et al., Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am. J. Respir. Crit. Care Med., 1998. 158: 998–1001.PubMedGoogle Scholar
  71. 71.
    Yano, T., Y. Ichikawa, S. Komatu, S. Arai, and K. Oizumi, Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am. J. Respir. Crit. Care Med., 1994. 149: 1348–1353.PubMedGoogle Scholar
  72. 72.
    Marc, E., et al., Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia. Pediatr. Infect. Dis. J., 2000. 19: 706–710.PubMedCrossRefGoogle Scholar
  73. 73.
    Sabato, A.R., et al., Mycoplasma pneumoniae: Acute illness, antibiotics, and subsequent pulmonary function. Arch. Dis. Child., 1984. 59: 1034–1037.PubMedCrossRefGoogle Scholar
  74. 74.
    Mok, J.Y., P.R. Waugh, and a.H. Simpson, Mycoplasma pneumoniae infection. A follow-up study of 50 children with respiratory illness. Arch. Dis. Child., 1979. 54: 506–511.PubMedCrossRefGoogle Scholar
  75. 75.
    Wongtim, S., and S. Mogmued, Methacholine inhalation challenge in patients with post Mycoplasma pneumoniae pneumonia. Asian Pac. J. Allergy Immunol., 1995. 13: 5–10.PubMedGoogle Scholar
  76. 76.
    Chu, H.W., et al., Substance P and its receptor neurokinin 1 expression in asthmatic airways. J. Allergy Clin. Immunol., 2000. 106: 713–722.PubMedCrossRefGoogle Scholar
  77. 77.
    Tipirneni, P., B.S. Moore, J.S. Hyde, and V. Schauf, IgE antibodies to Mycoplasma pneumoniae in asthma and other atopic diseases. Ann. Allergy, 1980. 45: 1–7.PubMedGoogle Scholar
  78. 78.
    Bar Meir, E., et al., Mycoplasma-pneumoniae-induced thrombotic thrombocytopenic purpura. Acta Haematol., 2000. 103: 112–115.PubMedCrossRefGoogle Scholar
  79. 79.
    Koletsky, R.J. and A.J. and Weinstein, Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature. Am. Rev. Respir: Dis., 1980. 122: 491–496.Google Scholar
  80. 80.
    Cassell, G.H. and a.B.C. Cole, Mycoplasmas as agents of human disease. N. Engl. J. Med., 1981. 304: 80–89.Google Scholar
  81. 81.
    Rautonen, J., M. Koskiniemi, and A. Vaheri, Prognostic factors in childhood acute encephalitis. Pediatr. Infect. Dis. J., 1991. 10: 441–446.PubMedCrossRefGoogle Scholar
  82. 82.
    Bitnun A, F.-J.E., Petric M, et al, Acute childhood encephalitis and Mycoplasma pneumoniae. Clin. Infect. Dis., 2001. 32: 1674–1684.PubMedCrossRefGoogle Scholar
  83. 83.
    Smith, R. and L. Eviatar, Neurologic manifestations of Mycoplasma pneumoniae infections: diverse spectrum of diseases. A report of six cases and review of the literature. Clin. Pediatr., 2000. 39: 195–201.CrossRefGoogle Scholar
  84. 84.
    Beskind, D.L. and S.M. Keim, Choreoathetotic movement disorder in a boy with Mycoplasma pneumoniae encephalitis. Ann. Emerg. Med., 1994. 23: 1375–1378.PubMedCrossRefGoogle Scholar
  85. 85.
    Keegan, B.M., N.J. Lowry, and J.Y. Yager, Mycoplasma pneumoniae: a cause of coma in the absence of meningoencephalitis. Pediatr. Neurol., 1999. 21: 822–825.PubMedCrossRefGoogle Scholar
  86. 86.
    Kikuchi, M., et al., Bickerstaff’s brainstem encephalitis associated with IgG anti-GQ1b antibody subsequent to Mycoplasma pneumoniae infection: favorable response to immunoadsorption therapy. J. Child Neurol., 1997. 12: 403–405.PubMedCrossRefGoogle Scholar
  87. 87.
    Decaux, G., et al., Central nervous system complications of Mycoplasma pneumoniae. J. Neurol. Neurosurg. Psychiatr., 1980. 43: 883–887.PubMedCrossRefGoogle Scholar
  88. 88.
    Nishimura, M., et al., Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection. J. Neurol. Sci., 1996. 140: 91–95.PubMedCrossRefGoogle Scholar
  89. 89.
    Bencina D, D.P., Mueller-Premru M, et al, Intrathecal synthesis of specific antibodies in patients with invasion of the central nervous system by Mycoplasma pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis., 2000. 19: 521–530.PubMedCrossRefGoogle Scholar
  90. 90.
    Narita, M., et al., Survey of mycoplasmal bacteremia detected in children by polymerase chain reaction. Clin. Infect. Dis., 1996. 23: 522–525.PubMedCrossRefGoogle Scholar
  91. 91.
    Narita, M., O. Itakura, T. Matsuzono, et al, Analysis of mycoplasmal central nervous system involvement by polymerase chain reaction. Pediatr. Infect. Dis. J., 1995. 14: 236–237.PubMedCrossRefGoogle Scholar
  92. 92.
    Narita, M, S. Yamada, Two distinct patterns of central nervous system complications due to Mycoplasma pneumoniae infection (Letter). Clin. Infect. Dis., 2001. 33: 916–917.PubMedCrossRefGoogle Scholar
  93. 93.
    Pfausler, B., et al., Post-infectious central and peripheral nervous system diseases complicating Mycoplasma pneumoniae infection. Report of three cases and review of the literature. Eur. J. Neurol., 2002. 9: 93–96.PubMedCrossRefGoogle Scholar
  94. 94.
    Socan, M., I. Ravnik, D. Bencina, et al., Neurological symptoms in patients whose cerebrospinal fluid is culture- and/or polymerase chain reaction-positive for Mycoplasma pneumoniae. Clin. Infect. Dis., 2001. 32: E31–E33.PubMedCrossRefGoogle Scholar
  95. 95.
    Hajjeh, R.A., R.D., P.R. Cieslak, A.N. Sofair,D. Passaro, J. Flood, J. Johnson, J.K. Hacker, W.J. Shieh, R.M. Hendry, S. Nikkari, S. Ladd-Wilson, J. Hadler, J. Rainbow, J.W. Tappero, C.W. Woods, L. Conn, S. Reagan, S. Zaki, and B.A. Perkins, Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995–1998. Emerg. Infect. Dis., 2002. 8(2): 145–53.PubMedCrossRefGoogle Scholar
  96. 96.
    Farraj, R.S., et al., Mycoplasma-associated pericarditis. Mayo Clin. Proc., 1997. 72: 33–36.PubMedCrossRefGoogle Scholar
  97. 97.
    Karjalainen, J., A loud third heart sound and asymptomatic myocarditis during Mycoplasma pneumoniae infection. Eur. Heart J., 1990. 11: 960–963.PubMedGoogle Scholar
  98. 98.
    Ponka, A., Carditis associated with Mycoplasma pneumoniae infection. Acta Med. Scand., 1979. 206: 77–86.PubMedCrossRefGoogle Scholar
  99. 99.
    Vitullo, B.B., S. O’Regan, J.P. de Chadarevian, and B.S. Kaplan, Mycoplasma pneumonia associated with acute glomerulonephritis. Nephron, 1978. 21: 284–288.Google Scholar
  100. 100.
    Kanayama, Y., et al., Mycoplasma pneumoniae pneumonia associated with IgA nephropathy. Scand. J. Infect. Dis., 1982. 14: 231–233.PubMedGoogle Scholar
  101. 101.
    Pasternack, A., et al., Acute tubulointerstitial nephritis in a patient with Mycoplasma pneumoniae infection. Scand. J. Infect. Dis., 1979. 11: 85–87.Google Scholar
  102. 102.
    Schulman, P., T.C. Piemonte, and B. Singh, Acute renal failure, hemolytic anemia, and Mycoplasma pneumoniae. JAMA, 1980. 244: 1823–1824.PubMedCrossRefGoogle Scholar
  103. 103.
    Von Bonsdorff, M., A. Ponka, and T. Tornroth, Mycoplasmal pneumonia associated with mesangiocapillary glomerulonephritis type II (dense deposit disease). Acta Med. Scand., 1984. 216: 427–429.Google Scholar
  104. 104.
    Agustin, E.T., V. Gill, and B.A. Cunha, Mycoplasma pneumoniae meningoencephalitis complicated by diplopia. Heart Lung, 1994. 23: 436–437.PubMedGoogle Scholar
  105. 105.
    Hernandez, L.A., G.E. Urquhart, and W.C. Dick, Mycoplasma pneumoniae infection and arthritis in man. Br. Med. J., 1977. 2: 14–16.PubMedCrossRefGoogle Scholar
  106. 106.
    Lambert, H., Syndrome with joint manifestations in association with Mycoplasma pneumoniae infection. Br. Med. J., 1968. iii:156–157.CrossRefGoogle Scholar
  107. 107.
    Taylor-Robinson, D., Mycoplasmal arthritis in man. Isr. J. Med. Sci., 1981. 17: 616–621.PubMedGoogle Scholar
  108. 108.
    Davis, C.P., et al., Isolation of Mycoplasma pneumoniae from synovial fluid samples in a patient with pneumonia and polyarthritis. Arch. Intern. Med., 1988. 148: 969–970.PubMedCrossRefGoogle Scholar
  109. 109.
    Poggio, T.V., N. Orlando, L. Galanternik, and S. Grinstein, Microbiology of acute arthropathies among children in Argentina: Mycoplasma pneumoniae and hominis and Ureaplasma urealyticum. Pediatr. Infect. Dis. J., 1998. 17: 304–308.PubMedCrossRefGoogle Scholar
  110. 110.
    Levine, D.P. and A.M. Lerner, The clinical spectrum of Mycoplasma pneumoniae infections. Med. Clin. N. Am., 1978. 62: 961–978.PubMedGoogle Scholar
  111. 111.
    Levy, M. and N.H. Shear, Mycoplasma pneumoniae infections and Stevens-Johnson syndrome. Report of eight cases and review of the literature. Clin. Pediatr., 1991. 30: 42–49.CrossRefGoogle Scholar
  112. 112.
    Stevens, D., et al., Mycoplasma pneumoniae infections in children. Arch. Dis. Child., 1978. 53: 38–42.PubMedCrossRefGoogle Scholar
  113. 113.
    Fournier, S., S. Bastuji Garin, H. Mentec, J. Revuz, and J.C. Roujeau, Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection [letter]. Eur. J. Clin. Microbiol. Infect. Dis., 1995. 14: 558–559.PubMedCrossRefGoogle Scholar
  114. 114.
    Nagayama, Y., N. Sakurai, and K. Yamamoto, Clinical observations of children with pleuropneumonia due to Mycoplasma pneumoniae. Ped. Pulmonol., 1990. 8: 182–187.CrossRefGoogle Scholar
  115. 115.
    Macfarlane, J., Mycoplasma pneumoniae infection, antibiotics and exanthema. Infection, 1980. 8: 119–120.PubMedCrossRefGoogle Scholar
  116. 116.
    Foy, H.M., C.M. Nolan, and I.D. Allan, Epidemiologic aspects of M. pneumoniae disease complications: a review. Yale J. Biol. Med., 1983. 56: 469–473.PubMedGoogle Scholar
  117. 117.
    Cherry, J.D., Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin. Infect. Dis., 1993. 17(Suppl. 1): S47–S51.PubMedCrossRefGoogle Scholar
  118. 118.
    el-Khatib, M. and A.M. Lerner, Myocarditis in Mycoplasma pneumoniae pneumonia. Occurrence with hemolytic anemia and extraordinary titers of cold isohemagglutinins. JAMA, 1975. 231: 493–494.PubMedCrossRefGoogle Scholar
  119. 119.
    Simonian, N. and D. Janner, Pleural effusion, hepatitis and hemolytic anemia in a twelve-year-old male child. Pediatr. Infect. Dis. J., 1998. 17: 173–177.PubMedCrossRefGoogle Scholar
  120. 120.
    Turtzo, D.F. and P.K. Ghatak, Acute hemolytic anemia with Mycoplasma pneumoniae pneumonia. JAMA, 1976. 236: 1140–1141.PubMedCrossRefGoogle Scholar
  121. 121.
    Bar-Meir, E., H. Amital, Y. Levy, A. Kneller, Y. Bar-Dayan, and Y. Shoenfeld, Mycoplasma-pneumoniae-induced thrombotic thrombocytopenic purpura. Acta Haematol., 2000. 103: 112–115.PubMedCrossRefGoogle Scholar
  122. 122.
    Stephan, J.L., et al., Aplastic anemia after Mycoplasma pneumoniae infection: a report of two cases. J. Pediatr. Hematol. Oncol., 1999. 21: 299–302.PubMedCrossRefGoogle Scholar
  123. 123.
    Control, C.f.D., Outbreaks of Mycoplasma pneumoniae respiratory infection-Ohio, Texas, and New York, 1993. Morbid. Mortal. Weekly Rep., 1993. 42: 931–1039.Google Scholar
  124. 124.
    Milla, E., L. Zografos, and B. Piguet, Bilateral optic papillitis following Mycoplasma pneumoniae pneumonia. Ophthalmologica, 1998. 212: 344–346.PubMedCrossRefGoogle Scholar
  125. 125.
    Salzman, M.B., et al., Ocular manifestations of Mycoplasma pneumoniae infection. Clin. Infect. Dis., 1992. 14: 1137–1139.PubMedCrossRefGoogle Scholar
  126. 126.
    Murray, H.W., et al., The protean manifestations of Mycoplasma pneumoniae infection in adults. Am. J. Med., 1975. 58: 229–242.PubMedCrossRefGoogle Scholar
  127. 127.
    Arav-Boger, R., et al., Cholestatic hepatitis as a main manifestation of Mycoplasma pneumoniae infection. J. Pediatr. Gastroenterol. Nutr., 1995. 21: 459–460.PubMedCrossRefGoogle Scholar
  128. 128.
    Goulet, M., et al., Isolation of Mycoplasma pneumoniae from the human urogenital tract. J. Clin. Microbiol., 1995. 33: 2823–2825.PubMedGoogle Scholar
  129. 129.
    Edwards, E.A., et al., A longitudinal study of Mycoplasma pneumoniae: infections in Navy recruits by isolation and seroepidemiology. Am. J. Epidemiol., 1976. 104: 556–562.PubMedGoogle Scholar
  130. 130.
    Gray, G.C., et al., Respiratory diseases among U. S. military personnel: countering emerging threats. Emerg. Infect. Dis., 1999. 5: 379–385.PubMedCrossRefGoogle Scholar
  131. 131.
    Gray, G.C., et al., Mycoplasma pneumoniae: a frequent cause of pneumonia among U. S. Marines in southern California. Mil. Med., 1997. 162: 524–526.PubMedGoogle Scholar
  132. 132.
    Mogabgab, W.J., Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959–1966. Am. Rev. Respir. Dis., 1968. 97: 345–379.Google Scholar
  133. 133.
    Fisher, B., B. Yu, D. Armstrong, and J. Magill, Outbreak of Mycoplasma pneumoniae infection among hospital personnel. Am. J. Med. Sci., 1978. 276: 205–209.PubMedCrossRefGoogle Scholar
  134. 134.
    Kashiwagi, S., et al., An outbreak of Mycoplasma pneumoniae infections in a hospital in Japan. Kurume Med. J., 1985. 32: 293–296.PubMedCrossRefGoogle Scholar
  135. 135.
    Kleemola, M., C. Jokinen, et al., Outbreak of Mycoplasma pneumoniae infection among hospital personnel studied by a nucleic acid hybridization test. J. Hosp. Infect., 1992. 21: 213–221.PubMedCrossRefGoogle Scholar
  136. 136.
    Leibowitz, Z., P. Schvartzman, L. Epstein, I. Lis, and Y. Naot, An outbreak of Mycoplasma pneumoniae pneumonia in two kibbutzim: a clinical and epidemiologic study. Isr. J. Med. Sci., 1988. 24: 88–92.PubMedGoogle Scholar
  137. 137.
    Muldoon, R.L., et al., An outbreak of Mycoplasma pneumoniae respiratory illness in a semi-closed religious commune. Ann. Emerg. Med., 1982. 11: 613–615.PubMedCrossRefGoogle Scholar
  138. 138.
    Hyde, T.B., et al., Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis, 2001. 183(6): 907–912.PubMedCrossRefGoogle Scholar
  139. 139.
    Klausner, J.D., et al., Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis. J Infect Dis, 1998. 177(1): 161–166.PubMedCrossRefGoogle Scholar
  140. 140.
    Sterner, G., et al., Acute respiratory illness with Mycoplasma pneumoniae: An outbreak in a home for children. Acta Paediatr. Scand, 1966. 55: 280–286.PubMedCrossRefGoogle Scholar
  141. 141.
    Broome, C.V., et al., An explosive outbreak of Mycoplasma pneumoniae infection in a summer camp. Pediatrics, 1980. 66: 884–888.PubMedGoogle Scholar
  142. 142.
    Gray, G.C., et al., Pneumonia hospitalizations in the US Navy and Marine Corps: rates and risk factors for 6,522 admissions, 1981–1991. Am. J. Epidemiol., 1994. 139: 793–802.PubMedGoogle Scholar
  143. 143.
    Alexander, E.R., et al., Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group. N. Engl. J. Med, 1966. 275: 131–136.PubMedCrossRefGoogle Scholar
  144. 144.
    Foy, H.M., et al., Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA, 1970. 214:1666–1672.PubMedCrossRefGoogle Scholar
  145. 145.
    Dorigo-Zetsma, J.W., et al., Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J. Infect. Dis., 2001. 183: 675–678.PubMedCrossRefGoogle Scholar
  146. 146.
    Balassanian, N. and F.C. Robbins, Mycoplasma pneumoniae infection in families. N. Engl. J. Med., 1967. 277: 719–725.Google Scholar
  147. 147.
    Biberfeld, G. and G. Sterner, A study of Mycoplasma pneumoniae infections in families. Scand. J. Infect. Dis., 1969. 1: 39–46.PubMedGoogle Scholar
  148. 148.
    Foy, H.M., et al., Epidemiology of Mycoplasma pneumoniae infection in families. J. Am. Med. Assoc., 1966. 197: 859–866.CrossRefGoogle Scholar
  149. 149.
    Jensen, K.J., et al., Mycoplasma pneumoniae infections in children. An epidemiologic appraisal in families treated with oxytetracycline. Am. J. Epidemiol., 1967. 86: 419–432.PubMedGoogle Scholar
  150. 150.
    Sande, M.A., F. Gadot, and R.P. and Wenzel, Point source epidemic of Mycoplasma pneumoniae infection in a prosthodontics laboratory. Am. Rev. Respir. Dis., 1975. 112: 213–217.PubMedGoogle Scholar
  151. 151.
    Naftalin, J.M., et al., Letter: Mycoplasma pneumoniae septicemia. JAMA, 1974. 228(5): 565.PubMedCrossRefGoogle Scholar
  152. 152.
    Foy, H.M., Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin. Infect. Dis., 1993. 17(Suppl. 1): S37–S46.PubMedCrossRefGoogle Scholar
  153. 153.
    Krause, D.C., Mycoplasma pneumoniae cytadherence: organization and assembly of the attachment organelle. Trends Microbiol., 1998. 6: 15–18.PubMedCrossRefGoogle Scholar
  154. 154.
    Tryon, V.V. and J.B. Baseman, Pathogenic determinants and mechanisms., in Mycoplasmas: molecular biology and pathogenesis., J. Maniloff, Editor. 1992, American Society for Microbiology: Washington, D.C. pp. 457–471.Google Scholar
  155. 155.
    Baseman, J.B., M. Lange, N.L. Criscimagna, J.A. Giron, and C.A. Thomas, Interplay between mycoplasmas and host target cells. Microb Pathog 1995. 19: 105–116.PubMedCrossRefGoogle Scholar
  156. 156.
    Rottem, S., Invasion of mycoplasmas into and fusion with host cells., in Molecular biology and pathogenicity of mycoplasmas., S. Razin and R. Herrmann, Editors. 2002, Kluwer Academic/Plenum Publishers: New York, N.Y. 391–402.CrossRefGoogle Scholar
  157. 157.
    Rottem, S., Interaction of mycoplasmas with host cells. Physiol. Rev., 2003. 83: 417–432.PubMedGoogle Scholar
  158. 158.
    Somerson, N.L., B.E. Walls, and R.M. Chanock, Hemolysin of Mycoplasma pneumoniae: tentative identification as a peroxide. Science, 1965. 150: 226–228.PubMedCrossRefGoogle Scholar
  159. 159.
    Almagor, M., I. Kahane, and S. Yatziv, Role of superoxide anion in host cell injury induced by Mycoplasma pneumoniae infection. A study in normal and trisomy 21 cells. J. Clin. Investig., 1984. 73: 842–847.PubMedCrossRefGoogle Scholar
  160. 160.
    Jacobs, E., et al., Immunological reaction of guinea-pigs following intranasal Mycoplasma pneumoniae infection and immunization with the 168 kDa adherence protein. J. Gen. Microbiol., 1988. 134: 473–479.PubMedGoogle Scholar
  161. 161.
    Loos, M. and H. Brunner, Complement components (C1, C2, C3, C4) in bronchial secretions after intranasal infection of guinea pigs with Mycoplasma pneumoniae: dissociation of unspecific and specific defense mechanisms. Infect Immun, 1979. 25(2): 583–5.PubMedGoogle Scholar
  162. 162.
    Waites, K.B., et al., Pathogenesis of Mycoplasma pneumoniae infections: adaptive immunity, innate immunity, cell biology, and virulence factors, in Community Acquired Pneumonia, N. Suttorp and R. Marre, Editors 2007, Birkhäuser Publishing: Basel, Switzerland, pp. 183–199.Google Scholar
  163. 163.
    Yang, J., et al., Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev., 2004. 15(2–3): 157–168.PubMedCrossRefGoogle Scholar
  164. 164.
    Carpenter, T., Corticosteroids in the treatment of severe mycoplasma encephalitis in children. Crit. Care Med., 2002. 30:925–927.PubMedCrossRefGoogle Scholar
  165. 165.
    Gucuyener, K., et al., Methylprednisolone in neurologic complications of Mycoplasma pneumonia. Indian J. Pediatr., 2000. 67: 467–469.PubMedCrossRefGoogle Scholar
  166. 166.
    Foy, H.M., Loop, J., Clarke, E.R., Mansy, A.W., Spence, W.F., Feigl, P., et al., Radiographic study of mycoplasma pneumoniae pneumonia. Am. Rev. Respir. Dis., 1973. 108: 469–474.PubMedGoogle Scholar
  167. 167.
    Morozumi, M., Hasegawa, K., Kobayashi, R., Inoue, N., Iwata, S., Kuroki, H., et al., Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob. Agents Chemother., 2005. 49: 2302–2306.PubMedCrossRefGoogle Scholar
  168. 168.
    Couch, R.B., Infection with artificially propagated Eaton agent (Mycoplasma pneumoniae): implications for development of attenuated vaccine for cold agglutinin-positive pneumonia. JAMA, 1964. 187: 442–447.PubMedGoogle Scholar
  169. 169.
    Fernald, G.W. and W.A. Clyde, Jr., Protective effect of vaccines in experimental Mycoplasma pneumoniae disease. Infect. Immun., 1970. 1: 559–565.PubMedGoogle Scholar
  170. 170.
    Clyde, W.A., Jr., Immunopathology of experimental Mycoplasma pneumoniae disease. Infect. Immun., 1971. 4: 757–763.PubMedGoogle Scholar
  171. 171.
    Clyde, W.A., Jr., Mycoplasma pneumoniae pneumonia. Mil. Med., 1971. 136: 20–22.PubMedGoogle Scholar
  172. 172.
    Fernald, G.W. and W.P. Glezen, Humoral and cellular immune responses to an inactivated Mycoplasma pneumoniae vaccine in children. J. Infect. Dis., 1973. 127: 498–504.PubMedCrossRefGoogle Scholar
  173. 173.
    Yayoshi, M., E. Hayatsu, and M. Yoshioka, Protective effects of Mycoplasma pneumoniae live vaccine or its hyperimmune serum on the experimental infection in mice. Kansenshogaku Zasshi, 1989. 63: 684–691.PubMedGoogle Scholar
  174. 174.
    Cimolai, N., et al., Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol. Immunol., 1992. 36: 465–478.PubMedGoogle Scholar
  175. 175.
    Yayoshi, M., T. Sasaki, and M. Yoshioka, Relationship between an 85 kDa protein and the protective effects of Mycoplasma pneumoniae. Microbiol. Immunol., 1992. 36: 455–464.PubMedGoogle Scholar
  176. 176.
    Barile, M.F., et al., Protection of immunized and previously infected chimpanzees challenged with Mycoplasma pneumoniae. Vaccine, 1994. 12: 707–714.PubMedCrossRefGoogle Scholar
  177. 177.
    Franzoso, G., et al., Immunoblot analyses of chimpanzee sera after infection and after immunization and challenge with Mycoplasma pneumoniae. Infect. Immun., 1994. 62: 1008–1014.PubMedGoogle Scholar
  178. 178.
    Cimolai, N., et al., Bases for the early immune response after rechallenge or component vaccination in an animal model of acute Mycoplasma pneumoniae pneumonitis. Vaccine, 1995. 13: 305–309.PubMedCrossRefGoogle Scholar
  179. 179.
    Cimolai, N., et al., Mycoplasma pneumoniae reinfection and vaccination: protective oral vaccination and harmful immunoreactivity after re-infection and parenteral immunization. Vaccine, 1996. 14: 1479–1483.PubMedCrossRefGoogle Scholar
  180. 180.
    Ellison, J.S., L.D. Olson, and M.F. Barile, Immunity and vaccine development, in Mycoplasmas: molecular biology and pathogenesis., J. Maniloff, et al., Editors. 1992, American Society for Microbiology: Washington, D.C. pp. 491–504.Google Scholar
  181. 181.
    Barile, M.F., et al., Superiority of the chimpanzee animal model to study the pathogenicity of known Mycoplasma pneumoniae and reputed mycoplasma pathogens. Isr. J. Med. Sci., 1987. 23:556–560.PubMedGoogle Scholar
  182. 182.
    Steinberg, P., R.L. Horswood, and R.M. Chanock, Temperature-sensitive mutants of Mycoplasma pneumoniae. I. In vitro biologic properties. J. Infect. Dis., 1969. 120: 217–224.PubMedCrossRefGoogle Scholar
  183. 183.
    Steinberg, P., et al., Temperature-sensitive mutants of Mycoplasma pneumoniae. II. Response of hamsters. J. Infect. Dis., 1971. 124: 179–187.PubMedCrossRefGoogle Scholar
  184. 184.
    Brunner, H., et al., Decreased virulence and protective effect of genetically stable temperature sensitive mutants of Mycoplasma pneumoniae. Ann. N. Y. Acad. Sci., 1973. 225: 436–452.CrossRefGoogle Scholar
  185. 185.
    Greenberg, H., et al., Asymptomatic infection of adult volunteers with a temperature sensitive mutant of Mycoplasma pneumoniae. Proc. Natl. Acad. Sci. USA, 1974. 71: 4015–4019.PubMedCrossRefGoogle Scholar
  186. 186.
    Brunner, H., Protective efficacy of Mycoplasma pneumoniae polysaccharides. Isr. J. Med. Sci., 1981. 17: 678–681.PubMedGoogle Scholar
  187. 187.
    Brunner, H. and B. Prescott, Effect of Mycoplasma pneumoniae polysaccharides and glycolipids on prophylaxis of experimental disease. Semin. Infect. Dis., 1982. 4: 190–197.Google Scholar
  188. 188.
    Jacobs, E., et al., Host reactions to Mycoplasma pneumoniae infections in guinea-pigs preimmunized systemically with the adhesin of this pathogen. Microb. Pathog., 1988. 5: 259–265.PubMedCrossRefGoogle Scholar
  189. 189.
    Kende, M., Antibody response of animals to Mycoplasma pneumoniae measured by latex agglutination. Appl Microbiol., 1969. 17: 275–279.PubMedGoogle Scholar
  190. 190.
    Shepard, M.C., The recovery of pleuropneumonia-like organisms from Negro men with and without nongonococcal urethritis. Am. J. Syph. Gonorrhea Vener. Dis., 1954. 38: 113–124.PubMedGoogle Scholar
  191. 191.
    Tully, J.G., D. Taylor-Robinson, D.L. Rose, R.M. Cole, and J.M. Bove Mycoplasma genitalium, a new species from the human urogenital tract. Int J Sys Bacteriol, 1983. 33: 387–396.CrossRefGoogle Scholar
  192. 192.
    Horowitz, S., B. Evinson, A. Borer, and J. Horowitz, Mycoplasma fermentans in rheumatoid arthritis and other inflammatory arthritides. J Rheumatol, 2000. 27: 2747–2753.PubMedGoogle Scholar
  193. 193.
    Johnson, S., D. Sidebottom, F. Bruckner, and D. Collins, Identification of Mycoplasma fermentans in synovial fluid samples from arthritis patients with inflammatory disease. J Clin Microbiol, 2000. 38: 90–93.PubMedGoogle Scholar
  194. 194.
    Blanchard, A., and C. Bebear, Mycoplasmas of humans, in Molecular biology and pathogenicity of Mycoplasmas, Kluwer, S.R.R. Herrmann, Editor. 2002, Academic Plenum Publishers: New York. pp. 45–71.CrossRefGoogle Scholar
  195. 195.
    Webster, D., H. Windsor, C. Ling, D. Windsor, and D. Pitcher, Chronic bronchitis in immunocompromised patients: association with a novel Mycoplasma species. Eur. J. Clin. Microbiol. Inf., 2003. 22: 530–534.CrossRefGoogle Scholar
  196. 196.
    Cassell, G.H., et al., Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin. Microbiol. Rev., 1993. 6(1): 69–87.PubMedGoogle Scholar
  197. 197.
    Taylor-Robinson, D., K. Waites, and G. Cassell, Genital Mycoplasmas, in Atlas of Sexually Transmitted Diseases and AIDS, R.C. Ballard, S.A. Morse, K.K. Holmes, and A.A. Moreland Editor. 2003, Mosby: New York. pp. 127–139.Google Scholar
  198. 198.
    Robertson, J.A., and G.W. Stemke, Expanded serotyping scheme for Ureaplasma urealyticum strains isolated from humans. J. Clin. Microbiol., 1982. 15: 873–878.PubMedGoogle Scholar
  199. 199.
    Harasawa, R., Genetic relationships among mycoplasmas based on the 16S-23S rRNA spacer sequence. Microbiol. Immunol., 1999. 43: 127–132.PubMedGoogle Scholar
  200. 200.
    Kong, F., G. James, Z. Ma, S. Gordon, W. Bin, and G.L. Gilbert, Phylogenetic analysis of Ureaplasma urealyticum–support for the establishment of a new species, Ureaplasma parvum. Int. J. Syst. Bacteriol., 1999. 49 Pt 4: 1879–1889.PubMedCrossRefGoogle Scholar
  201. 201.
    Kong, F., Z. Ma, G. James, S. Gordon, and G.L. Gilbert, Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J. Clin. Microbiol., 2000. 38: 1175–1179.PubMedGoogle Scholar
  202. 202.
    Robertson, J.A., L.A. Howard, C.L. Zinner, and G.W. Stemke, Comparison of 16S rRNA genes within the T960 and parvo biovars of ureaplasmas isolated from humans. Int. J. Syst. Bacteriol., 1994. 44: 836–838.PubMedCrossRefGoogle Scholar
  203. 203.
    Robertson, J.A., et al., Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974). Int. J. Syst. Evol. Microbiol., 2002. 52: 587–597.PubMedGoogle Scholar
  204. 204.
    Robertson, J.A., A. Vekris, C. Bebear, and G.W. Stemke, Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum. J. Clin. Microbiol., 1993. 31: 824–830.PubMedGoogle Scholar
  205. 205.
    Kim, M., G. Kim, R. Romero, S.S. Shim, E.C. Kim, and B.H. Yoon, Biovar diversity of Ureaplasma urealyticum in amniotic fluid: distribution, intrauterine inflammatory response and pregnancy outcomes. J. Perinat. Med., 2003. 31: 146–152.PubMedCrossRefGoogle Scholar
  206. 206.
    Deguchi, T., T. Yoshida, T. Miyazawa, M. Yasuda, M. Tamaki, H. Ishiko, and S. Maeda, Association of Ureaplasma urealyticum (biovar 2) with nongonococcal urethritis. Sex. Transm. Dis., 2004. 31: 192–195.PubMedCrossRefGoogle Scholar
  207. 207.
    Yoshida, T., H. Ishiko, M. Yasuda, Y. Takahashi, Y. Nomura, Y. Kubota, M. Tamaki, S. Maeda, and T. Deguchi, Polymerase chain reaction-based subtyping of ureaplasma parvum and ureaplasma urealyticum in first-pass urine samples from men with or without urethritis. Sex. Transm. Dis., 2005. 32: 454–457.PubMedCrossRefGoogle Scholar
  208. 208.
    Abele-Horn, M., C. Wolff, P. Dressel, F. Pfaff, and A. Zimmermann, Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease. J. Clin. Microbiol., 1997. 35: 1199–1202.Google Scholar
  209. 209.
    Heggie, A.D., D. Bar-Shain, B. Boxerbaum, A.A. Fanaroff, M.A. O’Riordan, and J.A. Robertson, Identification and quantification of ureaplasmas colonizing the respiratory tract and assessment of their role in the development of chronic lung disease in preterm infants. Pediatr. Infect. Dis. J., 2001. 20: 854–859.PubMedCrossRefGoogle Scholar
  210. 210.
    Katz, B., P. Patel, L. Duffy, R. Schelonka, R. Dimmitt, and K. Waites, Differential pathogenicity of Ureaplasma urealyticum and Ureaplasma parvum in preterm neonates with bronchopulmonary dysplasia. J. Clin. Microbiol., 2005. 43: 4852–4854.Google Scholar
  211. 211.
    Mallard, K., K. Schopfer, and T. Bodmer, Development of real-time PCR for the differential detection and quantification of Ureaplasma urealyticum and Ureaplasma parvum. J. Microbiol. Methods, 2005. 60: 13–19.PubMedCrossRefGoogle Scholar
  212. 212.
    Cassell, G.H., K.B. Waites, and D.T. Crouse, Mycoplasmal Infections, in Infectious diseases of the Fetus and Newborn Infant, J.S. Remington, J.O. Klein, Editor. 2001, W.B. Saunders Co., Inc: Philadelphia. pp. 733–767.Google Scholar
  213. 213.
    Dallo, S.F. and J.B. Baseman, Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb. Pathog., 2000. 29: 301–309.PubMedCrossRefGoogle Scholar
  214. 214.
    Taylor-Robinson, D., H.A. Davies, P. Sarathchandra, and P.M. Furr, Intracellular location of mycoplasmas in cultured cells demonstrated by immunocytochemistry and electron microscopy. Int J Exp Pathol, 1991. 72: 705–714.PubMedGoogle Scholar
  215. 215.
    Boesen, T., N.U. Fedosova, M. Kjeldgaard, S. Birkelund, and G. Christiansen, Molecular design of Mycoplasma hominis Vaa adhesin. Protein Sci, 2001. 10: 2577–2586.PubMedCrossRefGoogle Scholar
  216. 216.
    Henrich, B., K. Lang, A. Kitzerow, C. MacKenzie, and U. Hadding, Truncation as a novel form of variation of the p50 gene in Mycoplasma hominis. Microbiology, 1998. 144 (Pt 11):2979–2985.PubMedCrossRefGoogle Scholar
  217. 217.
    Razin, S., D. Yogev and Y. Naot, Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev., 1998. 62: 1094–1156.PubMedGoogle Scholar
  218. 218.
    Zhang, Q., and K.S. Wise, Molecular basis of size and antigenic variation of a Mycoplasma hominis adhesin encoded by divergent vaa genes. Infect. Immun., 1996. 64: 2737–2744.PubMedGoogle Scholar
  219. 219.
    Zheng, X., L.J. Teng, H.L. Watson, J.I. Glass, A. Blanchard, and G.H. Cassell, Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation. Infect. Immun., 1995. 63:891–898.PubMedGoogle Scholar
  220. 220.
    Saada, A.B., Y. Terespolski, A. Adoni, and I. Kahane, Adherence of Ureaplasma urealyticum to human erythrocytes. Infect. Immun., 1991. 59: 467–469.PubMedGoogle Scholar
  221. 221.
    Busolo, F., R. Zanchetta, and G. Bertoloni, Mycoplasmic localization patterns on spermatozoa from infertile men. Fertil. Steril., 1984. 42: 412–417.PubMedGoogle Scholar
  222. 222.
    Shepard, M.C., and G.K. Masover, Special features of ureaplasmas, in The Mycoplasmas, M.F.Barile, S. Razin, Editor. 1979, Academic Press: New York. pp. 451–494.Google Scholar
  223. 223.
    Taylor-Robinson, D., P.M. Furr, and A.D. Webster,Ureaplasma urealyticum in the immunocompromised host. Pediatr. Infect. Dis. J., 1986. 5: S236–S238.CrossRefGoogle Scholar
  224. 224.
    Webster, A.D., P.M. Furr, N.C. Hughes-Jones, B.D. Gorick, and D. Taylor-Robinson, Critical dependence on antibody for defence against mycoplasma. Clin. Exp. Immunol., 1988. 71: 383–387.PubMedGoogle Scholar
  225. 225.
    Smith, D.G., W.C. Russell, and D. Thirkell, Adherence of Ureaplasma urealyticum to human epithelial cells. Microbiology, 1994. 140 (Pt 10): 2893–2898.PubMedCrossRefGoogle Scholar
  226. 226.
    Robertson, J.A., M.E. Stemler, and G.W. Stemke. , Immunoglobulin A protease activity of Ureaplasma urealyticum. J. Clin. Microbiol., 1984. 19: 255–258.PubMedGoogle Scholar
  227. 227.
    Glass, J.I., E.J. Lefkowitz, J.S. Glass, C.R. Heiner, E.Y. Chen, and G.H. Cassell, The complete sequence of the mucosal pathogen Ureaplasma urealyticum. Nature, 2000. 407: 757–762.PubMedCrossRefGoogle Scholar
  228. 228.
    De Silva, N.S., and P.A. Quinn, Characterization of phospholipase A1, A2, C activity in Ureaplasma urealyticum membranes. Mol. Cell. Biochem., 1999. 201: 159–167.CrossRefGoogle Scholar
  229. 229.
    De Silva, N.S., and P.A. Quinn, Endogenous activity of phospholipases A and C in Ureaplasma urealyticum. J. Clin. Microbiol., 1986. 23: 354–359.PubMedGoogle Scholar
  230. 230.
    De Silva, N.S., and P.A. Quinn, Localization of endogenous activity of phospholipases A and C in Ureaplasma urealyticum. J. Clin. Microbiol., 1991. 29: 1498–1503.PubMedGoogle Scholar
  231. 231.
    Gelfand, E.W., Unique susceptibility of patients with antibody deficiency to Mycoplasma infection. Clin. Infect. Dis., 1993. 17(Suppl. 1): S250–S253.PubMedGoogle Scholar
  232. 232.
    Waites, K.B., B. Katz, and R.L. Schelonka, Mycoplasmas and ureaplasmas as neonatal pathogens. Clin. Microbiol. Rev., 2005. 18(4): 757–789.PubMedCrossRefGoogle Scholar
  233. 233.
    Waites, K.B., D.T. Crouse, and G.H. Cassell, Systemic neonatal infection due to Ureaplasma urealyticum. Clin. Infect. Dis., 1993. 17 Suppl 1: S131–5.PubMedCrossRefGoogle Scholar
  234. 234.
    Cassell, G.H., et al., Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet, 1988. 2(8605):240–245.PubMedCrossRefGoogle Scholar
  235. 235.
    Izraeli, S., Z. Samra, L. Sirota, P. Merlob, and S. Davidson, Genital mycoplasmas in preterm infants: prevalence and clinical significance. Eur. J. Pediatr., 1991. 150: 804–807.PubMedCrossRefGoogle Scholar
  236. 236.
    Ollikainen, J., H. Hiekkaniemi, M. Korppi, H. Sarkkinen, and K. Heinonen., Ureaplasma urealyticum infection associated with acute respiratory insufficiency and death in premature infants. J. Pediatr., 1993. 122: 756–760.PubMedCrossRefGoogle Scholar
  237. 237.
    Cassell, G.H., K.B. Waites, D.T. Crouse, P.T. Rudd, K.C. Canupp, S. Stagno, and G.R. Cutter,Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet, 1988. 2: 240–245.PubMedCrossRefGoogle Scholar
  238. 238.
    Foy, H.M., G.E. Kenny, E.M. Levinsohn, and J.T. Grayston, Acquisition of mycoplasmata and T-strains during infancy. J. Infect. Dis., 1970. 121: 579–587.PubMedCrossRefGoogle Scholar
  239. 239.
    Waites, K.B., et al., Association of genital mycoplasmas with exudative vaginitis in a 10 year old: a case of misdiagnosis. Pediatrics, 1983. 71(2): 250–2.PubMedGoogle Scholar
  240. 240.
    Hammerschlag, M.R., B. Doraiswamy, P. Cox, M. Cummings, and W.M. McCormack, Colonization of sexually abused children with genital mycoplasmas. Sex. Transm. Dis., 1987. 14: 23–25.PubMedCrossRefGoogle Scholar
  241. 241.
    Waites, K.B., Y. Rikihisa, and D. Taylor-Robinson, Mycoplasma and ureaplasma, in Manual of clinical microbiology, P.R. Murray, et al., Editors. 2003, American Society for Microbiology: Washington, D.C. pp. 972–990.Google Scholar
  242. 242.
    Bebear, C.M., H. Renaudin, A. Charron, D. Gruson, M. Lefrancois, and C. Bebear, In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob. Agents Chemother., 2000. 44: 2557–2260.PubMedCrossRefGoogle Scholar
  243. 243.
    Waites, K.B., et al., Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas. Antimicrob. Agents Chemother., 2005. 49(6): 2541–2542.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Deborah F. Talkington
    • 1
  • Ken B. Waites
    • 2
  1. 1.Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and PreventionAtlantaUSA
  2. 2.Department of Pathology, WP 230, University of Alabama at BirminghamBirminghamUSA

Personalised recommendations